279 related articles for article (PubMed ID: 10956193)
1. Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puja G; Baraldi M; De Micheli C
J Med Chem; 2000 Jul; 43(15):2851-9. PubMed ID: 10956193
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
3. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
[TBL] [Abstract][Full Text] [Related]
4. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
[TBL] [Abstract][Full Text] [Related]
5. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones.
Zappalà M; Gitto R; Bevacqua F; Quartarone S; Chimirri A; Rizzo M; De Sarro G; De Sarro A
J Med Chem; 2000 Dec; 43(25):4834-9. PubMed ID: 11123993
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticonvulsant activity of new 2,3-benzodiazepines as AMPA receptor antagonists.
De Sarro A; De Sarro G; Gitto R; Grasso S; Micale N; Zappalà M
Farmaco; 1999 Mar; 54(3):178-87. PubMed ID: 10371031
[TBL] [Abstract][Full Text] [Related]
8. Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
Donevan SD; Yamaguchi S; Rogawski MA
J Pharmacol Exp Ther; 1994 Oct; 271(1):25-9. PubMed ID: 7525924
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
Gitto R; Orlando V; Quartarone S; De Sarro G; De Sarro A; Russo E; Ferreri G; Chimirri A
J Med Chem; 2003 Aug; 46(17):3758-61. PubMed ID: 12904081
[TBL] [Abstract][Full Text] [Related]
10. 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists.
De Sarro A; De Sarro G; Gitto R; Grasso S; Micale N; Quartarone S; Zappalà M
Bioorg Med Chem Lett; 1998 Apr; 8(8):971-6. PubMed ID: 9871522
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.
Vamecq J; Bac P; Herrenknecht C; Maurois P; Delcourt P; Stables JP
J Med Chem; 2000 Apr; 43(7):1311-9. PubMed ID: 10753468
[TBL] [Abstract][Full Text] [Related]
13. GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
de Sarro G; Chimirri A; De Sarro A; Gitto R; Grasso S; Giusti P; Chapman AG
Eur J Pharmacol; 1995 Dec; 294(2-3):411-22. PubMed ID: 8750701
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
Inami H; Shishikura JI; Yasunaga T; Hirano M; Kimura T; Yamashita H; Ohno K; Sakamoto S
Chem Pharm Bull (Tokyo); 2019; 67(7):699-706. PubMed ID: 31257325
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
Inami H; Shishikura J; Yasunaga T; Ohno K; Yamashita H; Kato K; Sakamoto S
Bioorg Med Chem; 2015 Apr; 23(8):1788-99. PubMed ID: 25792143
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Yamaguchi S; Donevan SD; Rogawski MA
Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
[TBL] [Abstract][Full Text] [Related]
17. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
Chapman AG; Smith SE; Meldrum BS
Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
[TBL] [Abstract][Full Text] [Related]
18. Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents.
De Sarro G; Ferreri G; Gareri P; Russo E; De Sarro A; Gitto R; Chimirri A
Pharmacol Biochem Behav; 2003 Feb; 74(3):595-602. PubMed ID: 12543224
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant activity evaluation of 6-substituted-[1,2,4]triazolo[3,4-a](tetrazolo[5,1-a])phthalazine derivatives.
Bian M; Deng XQ; Gong GH; Wei CX; Quan ZS
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):792-800. PubMed ID: 22994853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
